Genetic Engineering of Resident Bacteria in the Gut Microbiome
暂无分享,去创建一个
[1] H. Ploegh,et al. Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut. , 2023, Cell host & microbe.
[2] B. Ye,et al. Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice. , 2022, Cell host & microbe.
[3] P. Hsu,et al. Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome , 2022, Nature Biotechnology.
[4] Thomas M Groseclose,et al. Transcriptional programming in a Bacteroides consortium , 2022, Nature Communications.
[5] J. Larsbrink,et al. Investigation and Alteration of Organic Acid Synthesis Pathways in the Mammalian Gut Symbiont Bacteroides thetaiotaomicron , 2022, Microbiology spectrum.
[6] N. Segata,et al. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer , 2022, Nature Medicine.
[7] J. Wortman,et al. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. , 2022, The New England journal of medicine.
[8] D. Artis,et al. Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome , 2022, Cell.
[9] Joshua J. Hamilton,et al. Polysaccharide utilization loci in Bacteroides determine population fitness and community-level interactions. , 2022, Cell host & microbe.
[10] J. Hasty,et al. Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes , 2021, Cell.
[11] Byung-Kwan Cho,et al. Engineering Bacteroides thetaiotaomicron to produce non-native butyrate based on a genome-scale metabolic model-guided design. , 2021, Metabolic engineering.
[12] W. S. Denney,et al. Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study , 2021, Nature Metabolism.
[13] Benjamin M. Scott,et al. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease , 2021, Nature Medicine.
[14] Erin H Wilson,et al. A Computational Framework for Identifying Promoter Sequences in Nonmodel Organisms Using RNA-seq Data Sets. , 2021, ACS synthetic biology.
[15] T. Lu,et al. Synthetic Biology and Computer-Based Frameworks for Antimicrobial Peptide Discovery. , 2021, ACS nano.
[16] A. Guss,et al. Approaches to genetic tool development for rapid domestication of non-model microorganisms , 2021, Biotechnology for Biofuels.
[17] Paul J. McMurdie,et al. Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease , 2021, Gut microbes.
[18] Daniel J. Blankenberg,et al. Community-led, integrated, reproducible multi-omics with anvi’o , 2020, Nature Microbiology.
[19] M. Fischbach,et al. Bacterially Derived Tryptamine Increases Mucus Release by Activating a Host Receptor in a Mouse Model of Inflammatory Bowel Disease , 2020, iScience.
[20] S. Mazmanian,et al. The gut microbiota–brain axis in behaviour and brain disorders , 2020, Nature Reviews Microbiology.
[21] Alexander C. Reis,et al. An Automated Model Test System for Systematic Development and Improvement of Gene Expression Models. , 2020, ACS synthetic biology.
[22] Dae-Hee Lee,et al. A designed whole-cell biosensor for live diagnosis of gut inflammation through nitrate sensing. , 2020, Biosensors & bioelectronics.
[23] Harris H. Wang,et al. CRISPR RNA-guided integrases for high-efficiency and multiplexed bacterial genome engineering , 2020, bioRxiv.
[24] E. Pamer,et al. Functional and Genomic Variation between Human-Derived Isolates of Lachnospiraceae Reveals Inter- and Intra-Species Diversity. , 2020, Cell host & microbe.
[25] Peter T. McKenney,et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells , 2020, Nature.
[26] Christopher A. Voigt,et al. Genetic circuit design automation for the gut resident species Bacteroides thetaiotaomicron , 2020, Nature Biotechnology.
[27] Shane Thomas O’Donnell,et al. The Progress of Multi-Omics Technologies: Determining Function in Lactic Acid Bacteria Using a Systems Level Approach , 2020, Frontiers in Microbiology.
[28] Andrew C. Tolonen,et al. A Targetron-Recombinase System for Large-Scale Genome Engineering of Clostridia , 2019, mSphere.
[29] D. Figeys,et al. Advancing functional and translational microbiome research using meta-omics approaches , 2019, Microbiome.
[30] Bentley Lim,et al. Genetic Manipulation of Wild Human Gut Bacteroides , 2019, Journal of bacteriology.
[31] H. Flint,et al. Heterologous gene expression in the human gut bacteria Eubacterium rectale and Roseburia inulinivorans by means of conjugative plasmids. , 2019, Anaerobe.
[32] M. Fischbach,et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome , 2019, bioRxiv.
[33] A. Visel,et al. CRAGE enables rapid activation of biosynthetic gene clusters in undomesticated bacteria , 2019, Nature Microbiology.
[34] A. Arkin,et al. GapMind: Automated Annotation of Amino Acid Biosynthesis , 2019, mSystems.
[35] María-Eugenia Guazzaroni,et al. Recent advances in plasmid-based tools for establishing novel microbial chassis. , 2019, Biotechnology advances.
[36] L. Comstock,et al. Streamlined Genetic Manipulation of Diverse Bacteroides and Parabacteroides Isolates from the Human Gut Microbiota , 2019, mBio.
[37] K. Honda,et al. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus , 2019, Nature.
[38] K. Winzer,et al. A novel conjugal donor strain for improved DNA transfer into Clostridium spp. , 2019, Anaerobe.
[39] N. Minton,et al. RiboCas: A Universal CRISPR-Based Editing Tool for Clostridium. , 2019, ACS synthetic biology.
[40] G. Borisy,et al. Systematic evasion of the restriction-modification barrier in bacteria , 2019, Proceedings of the National Academy of Sciences.
[41] Colin J. Brislawn,et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.
[42] Katherine J Chou,et al. Developing Riboswitch-Mediated Gene Regulatory Controls in Thermophilic Bacteria. , 2019, ACS synthetic biology.
[43] Rafael Silva-Rocha,et al. Expanding the toolbox of broad host-range transcriptional terminators for Proteobacteria through metagenomics , 2018, bioRxiv.
[44] P. Bork,et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation , 2019, Nature Medicine.
[45] Paul Theodor Pyl,et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer , 2019, Nature Medicine.
[46] Lydia M. Contreras,et al. Regulatory non-coding sRNAs in bacterial metabolic pathway engineering. , 2019, Metabolic engineering.
[47] U. Müh,et al. A Xylose-Inducible Expression System and a CRISPR Interference Plasmid for Targeted Knockdown of Gene Expression in Clostridioides difficile , 2019, Journal of bacteriology.
[48] T. Guo,et al. A rapid and versatile tool for genomic engineering in Lactococcus lactis , 2019, Microbial Cell Factories.
[49] B. Ryffel,et al. A New Bifidobacteria Expression SysTem (BEST) to Produce and Deliver Interleukin-10 in Bifidobacterium bifidum , 2018, Front. Microbiol..
[50] Ying Zhang,et al. Evolution of the Natural Transformation Protein, ComEC, in Bacteria , 2018, Front. Microbiol..
[51] D. Antonopoulos,et al. Healthy infants harbor intestinal bacteria that protect against food allergy , 2018, Nature Medicine.
[52] Kamir J. Hiam,et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics , 2018, Science.
[53] Adam B Fisher,et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria , 2018, Nature Biotechnology.
[54] Amir I. Mina,et al. A selective gut bacterial bile salt hydrolase alters host metabolism , 2018, eLife.
[55] Jie Zhang,et al. Multiplexed CRISPR-Cpf1-Mediated Genome Editing in Clostridium difficile toward the Understanding of Pathogenesis of C. difficile Infection. , 2018, ACS synthetic biology.
[56] Weston R. Whitaker,et al. Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion. , 2018, Cell host & microbe.
[57] Timothy K Lu,et al. An ingestible bacterial-electronic system to monitor gastrointestinal health , 2018, Science.
[58] Weston R. Whitaker,et al. An exclusive metabolic niche enables strain engraftment in the gut microbiota , 2018, Nature.
[59] Eric J Alm,et al. Metagenomic mining of regulatory elements enables programmable species-selective gene expression , 2018, Nature Methods.
[60] Pamela A. Silver,et al. Engineering bacteria for diagnostic and therapeutic applications , 2018, Nature Reviews Microbiology.
[61] Vanni Bucci,et al. Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47. , 2018, ACS infectious diseases.
[62] Joseph A. Sorg,et al. Using CRISPR-Cas9-mediated genome editing to generate C. difficile mutants defective in selenoproteins synthesis , 2017, Scientific Reports.
[63] Howard M. Salis,et al. An automated model test system for systematic development and improvement of gene expression models , 2017, bioRxiv.
[64] Johannes Alneberg,et al. DESMAN: a new tool for de novo extraction of strains from metagenomes , 2017, Genome Biology.
[65] Finn Stirling,et al. Rational Design of Evolutionarily Stable Microbial Kill Switches. , 2017, Molecular cell.
[66] Nikhil U. Nair,et al. Toward a genetic tool development pipeline for host-associated bacteria. , 2017, Current opinion in microbiology.
[67] Jacob S. Lamson,et al. Magic Pools: Parallel Assessment of Transposon Delivery Vectors in Bacteria , 2017, mSystems.
[68] Michael Baym,et al. Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation , 2017, Nature Biotechnology.
[69] Weston R. Whitaker,et al. Tunable Expression Tools Enable Single-Cell Strain Distinction in the Gut Microbiome , 2017, Cell.
[70] Michael Zimmermann,et al. Engineered Regulatory Systems Modulate Gene Expression of Human Commensals in the Gut , 2017, Cell.
[71] William E Bentley,et al. Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models , 2017, Nature Communications.
[72] Jeffrey J. Tabor,et al. Engineering bacterial thiosulfate and tetrathionate sensors for detecting gut inflammation , 2017, Molecular systems biology.
[73] M. Fischbach,et al. Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota. , 2016, Cell host & microbe.
[74] Tetsuya Hayashi,et al. Counterselection employing mutated pheS for markerless genetic deletion in Bacteroides species. , 2016, Anaerobe.
[75] W. D. de Vos,et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice , 2016, Nature Medicine.
[76] Nigel P. Minton,et al. A roadmap for gene system development in Clostridium , 2016, Anaerobe.
[77] Christopher A. Voigt,et al. Genetic circuit design automation , 2016, Science.
[78] Paulo A. Garcia,et al. Microfluidic Screening of Electric Fields for Electroporation , 2016, Scientific Reports.
[79] Jason B. Williams,et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.
[80] James J Collins,et al. “Deadman” and “Passcode” microbial kill switches for bacterial containment , 2015, Nature chemical biology.
[81] Irene M. Brockman,et al. Dynamic metabolic engineering: New strategies for developing responsive cell factories , 2015, Biotechnology journal.
[82] Timothy K Lu,et al. Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota. , 2015, Cell systems.
[83] Yong-hui Shi,et al. Effects of different Lactobacillus reuteri on inflammatory and fat storage in high-fat diet-induced obesity mice model , 2015 .
[84] Richard J. Roberts,et al. REBASE—a database for DNA restriction and modification: enzymes, genes and genomes , 2009, Nucleic Acids Res..
[85] Jan-Peter van Pijkeren,et al. CRISPR–Cas9-assisted recombineering in Lactobacillus reuteri , 2014, Nucleic acids research.
[86] A. Camilli,et al. Multiplex genome editing by natural transformation , 2014, Proceedings of the National Academy of Sciences.
[87] J. Collins,et al. A brief history of synthetic biology , 2014, Nature Reviews Microbiology.
[88] A. Rudensky,et al. Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.
[89] Andrew D Ellington,et al. Generalized bacterial genome editing using mobile group II introns and Cre-lox , 2013, Molecular systems biology.
[90] Klaus Ley,et al. Bacterial colonization factors control specificity and stability of the gut microbiota , 2013, Nature.
[91] Drew Endy,et al. Precise and reliable gene expression via standard transcription and translation initiation elements , 2013, Nature Methods.
[92] Feng Zhang,et al. rNA-guided editing of bacterial genomes using crisPr-cas systems , 2016 .
[93] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[94] Yun Zhang,et al. A Mimicking-of-DNA-Methylation-Patterns Pipeline for Overcoming the Restriction Barrier of Bacteria , 2012, PLoS genetics.
[95] A. Parker,et al. Development of an IPTG inducible expression vector adapted for Bacteroides fragilis. , 2012, Plasmid.
[96] Simon R. Carding,et al. Treatment of colitis with a commensal gut bacterium engineered to secrete human tgf‐&bgr;1 under the control of dietary xylan , 2011, Inflammatory bowel diseases.
[97] Jizhong Zhou,et al. Ultrasound-Mediated DNA Transformation in Thermophilic Gram-Positive Anaerobes , 2010, PloS one.
[98] Farren J. Isaacs,et al. Tracking, tuning, and terminating microbial physiology using synthetic riboregulators , 2010, Proceedings of the National Academy of Sciences.
[99] Christopher A. Voigt,et al. Automated Design of Synthetic Ribosome Binding Sites to Precisely Control Protein Expression , 2009, Nature Biotechnology.
[100] K. T. Holland,et al. Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus , 2009, Gut.
[101] J. Heap,et al. A modular system for Clostridium shuttle plasmids. , 2009, Journal of microbiological methods.
[102] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[103] Erik Remaut,et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[104] Laura S. Frost,et al. Mobile genetic elements: the agents of open source evolution , 2005, Nature Reviews Microbiology.
[105] P. Dilger,et al. Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin‐2 in response to xylan , 2005, Journal of applied microbiology.
[106] J. Schölmerich,et al. Preventive Effects of Escherichia coli Strain Nissle 1917 on Acute and Chronic Intestinal Inflammation in Two Different Murine Models of Colitis , 2004, Clinical Diagnostic Laboratory Immunology.
[107] A. Lambowitz,et al. Use of computer-designed group II introns to disrupt Escherichia coli DExH/D-box protein and DNA helicase genes. , 2004, Journal of molecular biology.
[108] Jean Paul Remon,et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 , 2003, Nature Biotechnology.
[109] Jun Wang,et al. Production of Two Proteins Encoded by theBacteroides Mobilizable Transposon NBU1 Correlates with Time-Dependent Accumulation of the Excised NBU1 Circular Form , 2001, Journal of bacteriology.
[110] G. Pérez-Martínez,et al. Construction of compatible wide-host-range shuttle vectors for lactic acid bacteria and Escherichia coli. , 2001, Plasmid.
[111] W. Fiers,et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. , 2000, Science.
[112] J. Heap,et al. The ClosTron: Mutagenesis in Clostridium refined and streamlined. , 2010, Journal of microbiological methods.
[113] D. Hanahan,et al. Plasmid transformation of Escherichia coli and other bacteria. , 1991, Methods in enzymology.